These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9682833)

  • 1. [Phe1psi(CH2-NH)Gly2]-nociceptin-(1-13)NH2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord.
    Xu IS; Wiesenfeld-Hallin Z; Xu XJ
    Neurosci Lett; 1998 Jun; 249(2-3):127-30. PubMed ID: 9682833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that [Phe1 psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2, a peripheral ORL-1 receptor antagonist, acts as an agonist in the rat spinal cord.
    Carpenter KJ; Dickenson AH
    Br J Pharmacol; 1998 Nov; 125(5):949-51. PubMed ID: 9846631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supraspinal and spinal effects of [Phe1psi(CH2-NH)Gly2]-nociceptin(1-13)-NH2 on nociception in the rat.
    Candeletti S; Guerrini R; Calò G; Romualdi P; Ferri S
    Life Sci; 2000; 66(3):257-64. PubMed ID: 10666001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nociceptin and [Phe1psi (CH2-NH) Gly2]-nociceptin-(1-13)-NH2 on tonic activity of rat hypothalamic neurons.
    Yakimova KS; Pierau FK
    Neurosci Lett; 1999 Oct; 274(2):87-90. PubMed ID: 10553944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as an agonist of the orphanin FQ/nociceptin receptor in vivo.
    Grisel JE; Farrier DE; Wilson SG; Mogil JS
    Eur J Pharmacol; 1998 Sep; 357(1):R1-3. PubMed ID: 9788779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supraspinal hyperalgesia and spinal analgesia by [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 in rat.
    Wang YQ; Zhu CB; Cao XD; Wu GC
    Eur J Pharmacol; 1999 Jul; 376(3):R1-3. PubMed ID: 10448896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 is an agonist of the nociceptin (ORL1) receptor.
    Butour JL; Moisand C; Mollereau C; Meunier JC
    Eur J Pharmacol; 1998 May; 349(1):R5-6. PubMed ID: 9669489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central administration of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)-NH2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats.
    Kapusta DR; Chang JK; Kenigs VA
    J Pharmacol Exp Ther; 1999 Apr; 289(1):173-80. PubMed ID: 10087001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nociceptin receptor-mediated inhibition of the rat rostral ventrolateral medulla neurons in vitro.
    Chu X; Xu N; Li P; Wang JQ
    Eur J Pharmacol; 1999 Jan; 364(1):49-53. PubMed ID: 9920184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal [Nphe1]nociceptin( 1-13)NH2 selectively reduces the spinal inhibitory effect of nociceptin.
    Xu IS; Grass S; Calo G; Guerrini R; Wiesenfeld-Hallin Z; Xu XJ
    Life Sci; 2002 Jan; 70(10):1151-7. PubMed ID: 11848299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phe1psi(CH2-NH)Gly2]nociceptin-(1 - 13)-NH2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray.
    Chiou LC
    Br J Pharmacol; 1999 Sep; 128(1):103-7. PubMed ID: 10498840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor.
    Guerrini R; Caló G; Bigoni R; Rizzi A; Varani K; Toth G; Gessi S; Hashiba E; Hashimoto Y; Lambert DG; Borea PA; Tomatis R; Salvadori S; Regoli D
    J Med Chem; 2000 Jul; 43(15):2805-13. PubMed ID: 10956188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors.
    Okawa H; Nicol B; Bigoni R; Hirst RA; Calo G; Guerrini R; Rowbotham DJ; Smart D; McKnight AT; Lambert DG
    Br J Pharmacol; 1999 May; 127(1):123-30. PubMed ID: 10369464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new selective antagonist of the nociceptin receptor.
    Guerrini R; Calo G; Rizzi A; Bigoni R; Bianchi C; Salvadori S; Regoli D
    Br J Pharmacol; 1998 Jan; 123(2):163-5. PubMed ID: 9489602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nociceptin and the ORL-1 ligand [Phe1psi (CH2-NH)Gly2]nociceptin(1-13)NH2 exert anti-opioid effects in the Freund's adjuvant-induced arthritic rat model of chronic pain.
    Bertorelli R; Corradini L; Rafiq K; Tupper J; Calò G; Ongini E
    Br J Pharmacol; 1999 Nov; 128(6):1252-8. PubMed ID: 10578139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade effects of (Nphe1)Nociceptin(1-13)-NH(2) on anti-nociception induced by intrathecal administration of nociceptin in rats.
    Lu JT; Huang YH; Palmer PP; Xie GX; Gabriel A; Grond S; Yu LC
    Regul Pept; 2001 Sep; 101(1-3):81-5. PubMed ID: 11495682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic effects of [Nphe1]nociceptin(1-13)NH2 on nociceptin receptor mediated inhibition of cAMP formation in Chinese hamster ovary cells stably expressing the recombinant human nociceptin receptor.
    Hashimoto Y; Caló G; Guerrini R; Smith G; Lambert DG
    Neurosci Lett; 2000 Jan; 278(1-2):109-12. PubMed ID: 10643813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nociceptin/orphanin FQ and the pseudopeptide [Phe1Psi(CH2NH)Gly2]-nociceptin(1-13)-NH2 and their interaction with classic opioids in the modulation of thermonociception in the land snail Helix aspersa.
    Miller-Pérez C; Sánchez-Islas E; Pellicer F; Rodríguez-Manzo G; Cruz SL; León-Olea M
    Eur J Pharmacol; 2008 Feb; 581(1-2):77-85. PubMed ID: 18096155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cardiovascular activity following microinjection of novel opioid-like neuropeptide nociceptin (orphanin FQ) into the rat rostral ventrolateral medulla.
    Chu X; Xu N; Li P; Mao L; Wang JQ
    Brain Res; 1999 May; 829(1-2):134-42. PubMed ID: 10350539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the G-protein-coupled ORL1 receptor in the mouse spinal cord by [35S]-GTPgammaS binding and immunohistochemistry.
    Narita M; Mizoguchi H; Oji DE; Dun NJ; Hwang BH; Nagase H; Tseng LF
    Br J Pharmacol; 1999 Nov; 128(6):1300-6. PubMed ID: 10578145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.